A159 ANTI-TUMOR NECROSIS FACTOR THERAPY PERSISTENCE IN PATIENTS WITH PERIANAL CROHN’S DISEASE AND LUMINAL CROHN’S DISEASE: A COMPARATIVE COHORT STUDY

BACKGROUND: Anti-tumor necrosis factor therapy has revolutionized the management of Crohn’s disease. Despite its effectiveness, a substantial proportion of patients discontinue therapy over time. Evaluating drug persistence rates reveals a real-world pattern of biologic use. Perianal Crohn’s disease...

Full description

Saved in:
Bibliographic Details
Published in:J Can Assoc Gastroenterol
Main Authors: Fung, M, Chin Koon Siw, K, McCurdy, J D
Format: Artigo
Language:Inglês
Published: Oxford University Press 2021
Subjects:
Poster of Distinction
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7958712/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwab002.157
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items